This episode is part of the 'Project Optimus' series exploring oncology trial reform.

Overview: What is Project Optimus, and why is it reshaping the future of oncology drug development? In this kickoff episode, we unpack the FDA’s initiative to modernize dose optimization in cancer trials. Join host Abigail Beanie as she speaks with Audrey Finesso, Senior Director of Clinical Regulatory Strategy, and Luca Cantini, Medical Director of Oncology at Fortrea. Together, they explore the implications for sponsors, regulators, and—most importantly—patients.

Participants: 

·         Host: Abigail Beanie Global Data reporter for Clinical Trials Arena

·         Audrey Finesso, Senior Director of Clinical Regulatory Strategy, Fortrea

·         Luca Cantini, Medical Director, Oncology, Fortrea